Company: PFSA
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001013762-25-004396
Chunk: 740

Company: Profusa, Inc.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 4
Chunk 740
---
 of an aggregate of 7,347,500 private placement warrants
to our sponsor, I-Bankers, and Dawson James at a purchase price of $1.00 per private placement warrant, generating gross proceeds to the
Company of $7,347,500. The private placement warrants are identical to the public warrants sold in the IPO except that the private placement
warrants: (i) will not be redeemable by us and (ii) may be exercised for cash or on a cashless basis, in each case so long as they are
held by the initial purchasers or any of their permitted transferees. If the private placement warrants are held by holders other than
the initial purchasers or any of their permitted transferees, the private placement warrants will be redeemable by us and exercisable
by the holders on the same basis as the public warrants included in the units sold in the IPO. No underwriting discounts or commissions
were paid with respect to such sale. The issuance of the private placement warrant was made pursuant to the exemption from registration
contained in Section 4(a)(2) of the Securities Act of 1933, as amended. 

I-Bankers and Dawson James
were representatives of the several underwriters. The securities sold in the IPO were registered under the Securities Act on registration
statements on Form S-1 (Nos. 333-257156 and 333-261763). The SEC declared the registration statement effective on December 20, 2021. 

We paid a total of $3,450,000
in underwriting discounts and commissions and $609,623 for other costs and expenses related to the IPO. I-Bankers and Dawson James, representatives
of the several underwriters in the IPO, received a portion of the underwriting discounts and commissions related to the IPO. We also repaid
the promissory note to the Sponsor from the proceeds of the IPO. After deducting the underwriting discounts and commissions and incurred
offering costs, the total net proceeds from our IPO and the sale of the private placement warrants was $193,647,500, of which $191,647,500
(or $10.10 per unit sold in the IPO) was placed in the trust account. Other than as described above, no payments were made by us to directors,
officers or persons owning ten percent or more of our common stock or to their associates, or to our affiliates. 

Purchases of Equity Securities by the Issuer